Beilstein J. Org. Chem.2025,21, 1964–1972, doi:10.3762/bjoc.21.152
pathophysiological mediator in many human diseases and biological pathways. TricyclicprostaglandinD2metabolitemethylester (tricyclic-PGDM methyl ester), the major urinary metabolite of PGD2, can be used as a clinical indicator for PGD2 overproduction. However, the limited amount of tricyclic-PGDM methyl ester
synthesis of tricyclic-PGDM methyl ester in 9 steps and 8% overall yield.
Keywords: asymmetric total synthesis; oxidative radical cyclization; tricyclicprostaglandinD2metabolitemethylester; Introduction
Prostaglandins (PGs), a family of hormone-like lipid compounds, are ubiquitous natural products
prostaglandinD2metabolitemethylester (tricyclic-PGDM methyl ester, 4), the major urinary metabolite of PGD2, has been used as an indicator for PGD2 overproduction. Roberts and associates established an assay for tricyclic-PGDM measurement using 18O-labelled tricyclic-PGDM methyl ester 8, which is an
PDF
Graphical Abstract
Scheme 1:
Representative prostaglandins and general synthetic strategy toward PGDM methyl ester 4.